SI
SI
discoversearch

Biotech / Medical : Guidant (GDT)

 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: Lighthouse who wrote (203)8/29/2002 10:18:03 AM
From: LighthouseRead Replies (1) of 235
 
Mid quarter call tightens ranges at the upper end of estimates. Look for $2.08 as the new 2002 estimate. Sales for the year will easily eclipse $3 billion.

CRM division is knocking the cover off the ball. IF momentum continues apace: The CRM division will shortly be worth around $30 per share on its own. (B/C Sales next year in this CRM division may top $1.8 billion. At 5 times sales on a product with mid 70% gross margins and an operating margin North of 20% and very large cash conversion rates on net income should be worth a multiple on sales)

I agree with some wags that the Cook acquisition is really just a $50 million option (breakup fee) on the stent market. Have to wait until mid September to find out what the judge has to say on enjoining the Cook/GDT stent data. I have no earthly idea as to handicaping how the judge will rule.

Anyone have a different take or am I the only one posting on this board anymore?

Cheers,
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

Copyright © 1995-2014 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.